Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail
-

Meet Jeanne Ireland, Assistant Commissioner for Legislation

Jeanne Ireland

Jeanne Ireland is the assistant commissioner for legislation at the Food and Drug Administration (FDA).

Ms. Ireland leads efforts to advance FDA’s legislative priorities. Her responsibilities include

  • advising and assisting key FDA officials concerning legislative needs, pending legislation, and oversight activities that affect the Agency
  • serving as the focal point for legislative liaison activities within FDA and between FDA, the Department of Health and Human Services, and other agencies
  • advising and assisting Members of Congress and congressional committees and staffs, in consultation with the Office of the Secretary, on agency actions, policies, and issues related to legislation which may affect FDA

Ms. Ireland received a B.A. from the University of Virginia and an A.M. from the University of Chicago.

Prior to this position, Ms. Ireland served as chief public health advisor to former chairman John D. Dingell on the House Energy and Commerce Committee, where she oversaw legislative efforts to regulate tobacco, improve the safety of the food supply, and increase oversight of imported drugs and medical devices.

From 2002 to 2008, Ms. Ireland was director of public policy at the Elizabeth Glaser Pediatric AIDS Foundation, where she directed the foundation’s advocacy for expanding global HIV/AIDS prevention, care, and treatment.

From 2001 to 2002, Ms. Ireland was a fellow with the Robert Bosch Foundation in Berlin, where she focused on German work/life policies.

From 1997 to 2001, as minority staff director for the Senate Health, Education, Labor and Pensions (HELP) Committee's Subcommittee on Children and Families, she advised Senator Christopher Dodd on child-care and health issues, including the FDA Modernization Act of 1997 and the creation of incentives for pediatric drug testing.

Prior to this position, Ms. Ireland spent four years working in a variety of positions at the Department of Health and Human Services as a presidential management fellow.

-
-